StockNews.com started coverage on shares of 22nd Century Group (NASDAQ:XXII – Free Report) in a research note released on Friday morning. The firm issued a sell rating on the biotechnology company’s stock.
22nd Century Group Price Performance
Shares of 22nd Century Group stock opened at $0.26 on Friday. The business has a 50 day moving average price of $0.54 and a 200 day moving average price of $5.07. The company has a market capitalization of $2.16 million, a P/E ratio of 0.00 and a beta of 1.41. 22nd Century Group has a 1 year low of $0.24 and a 1 year high of $18.24.
22nd Century Group (NASDAQ:XXII – Get Free Report) last issued its quarterly earnings data on Tuesday, August 13th. The biotechnology company reported ($0.36) earnings per share (EPS) for the quarter. The company had revenue of $7.95 million during the quarter. 22nd Century Group had a negative net margin of 275.12% and a negative return on equity of 380.39%.
Institutional Trading of 22nd Century Group
About 22nd Century Group
22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.
Read More
- Five stocks we like better than 22nd Century Group
- How to Find Undervalued Stocks
- 3 Stocks That Could Rise on European Bank Interest Rate Cuts
- EV Stocks and How to Profit from Them
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- Basic Materials Stocks Investing
- MarketBeat Week in Review – 9/16 – 9/20
Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.